Back
Citius Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
CTXR
Citius Pharmaceuticals
Last Price:
$0.85
Seasonality Move:
-17.5%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and CTXR is experiencing slight selling pressure.
Citius Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.79 | Buy |
| 20-day SMA: | 0.8 | Buy |
| 50-day SMA: | 1.11 | Sell |
| 200-day SMA: | 6.38 | Sell |
| 8-day EMA: | 0.82 | Buy |
| 20-day EMA: | 0.85 | Sell |
| 50-day EMA: | 1.23 | Sell |
| 200-day EMA: | 5.88 | Sell |
Citius Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 45.7 | Sell |
| Chaikin Money Flow: | -40039 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.74 - 0.92) | Buy |
| Bollinger Bands (100): | (0.93 - 2.99) | Sell |
Citius Pharmaceuticals Technical Analysis
| May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Citius Pharmaceuticals Stock
Is Citius Pharmaceuticals Stock a Buy?
-
Citius Pharmaceuticals share price is 0.85 while CTXR 8-day simple moving average is 0.79, which is a Buy signal.
-
The stock price of CTXR is 0.85 while Citius Pharmaceuticals 20-day SMA is 0.80, which makes it a Buy.
-
Citius Pharmaceuticals 50-day simple moving average is 1.11 while CTXR share price is 0.85, making it a Sell technically.
-
CTXR stock price is 0.85 and Citius Pharmaceuticals 200-day simple moving average is 6.38, creating a Sell signal.
CTXR Technical Analysis vs Fundamental Analysis
Sell
37
Citius Pharmaceuticals (CTXR)
is a Sell
Is Citius Pharmaceuticals a Buy or a Sell?
-
Citius Pharmaceuticals stock is rated a SellThe current Citius Pharmaceuticals [CTXR] share price is $0.85. The Score for CTXR is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Citius Pharmaceuticals Stock Info
Market Cap:
7.3M
Price in USD:
0.85
Share Volume:
93K
Citius Pharmaceuticals 52-Week Range
52-Week High:
26.25
52-Week Low:
0.65
Sell
37
Citius Pharmaceuticals (CTXR)
is a Sell
Citius Pharmaceuticals Share Price Forecast
-
What is the Citius Pharmaceuticals stock price today?The Citius Pharmaceuticals stock price is 0.85 USD today.
-
Will CTXR stock go up or go down?Citius Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Citius Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Citius Pharmaceuticals is overvalued.
Is Citius Pharmaceuticals Stock a Buy?
-
Citius Pharmaceuticals share price is 0.85 while CTXR 8-day exponential moving average is 0.82, which is a Buy signal.
-
The stock price of CTXR is 0.85 while Citius Pharmaceuticals 20-day EMA is 0.85, which makes it a Sell.
-
Citius Pharmaceuticals 50-day exponential moving average is 1.23 while CTXR share price is 0.85, making it a Sell technically.
-
CTXR stock price is 0.85 and Citius Pharmaceuticals 200-day simple moving average is 5.88, creating a Sell signal.
Fundamental Analysis of Citius Pharmaceuticals
Is Citius Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.88 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.02 per share, and an increase next year of $0.19 per share.
Technical Analysis of Citius Pharmaceuticals
Should I short Citius Pharmaceuticals stock?
-
CTXR Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting Citius Pharmaceuticals is a Sell
-
Citius Pharmaceuticals Relative Strength Index (RSI) is 45.7, which suggest Citius Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Citius Pharmaceuticals is (0.74 - 0.92), which suggest Citius Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Citius Pharmaceuticals is (0.93 - 2.99), which suggest Citius Pharmaceuticals is a Sell
* Citius Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.